Madiha Derouazi Amal Therapeutics, Geneva, Switzerland, Switzerland,
1 protocol

Elodie Belnoue Amal Therapeutics, Geneva, Switzerland, Switzerland,
1 protocol

Nicolas Molnarfi Department of Pathology and Immunology, School of Medicine, University of Geneva, Switzerland, Switzerland,
1 protocol

Mahdia Benkhoucha Department of Pathology and Immunology, School of Medicine, University of Geneva, Switzerland, Switzerland,
1 protocol

Patrice H Lalive
  • 1 Author merit
1 Protocol published
In-vivo gp100-specific Cytotoxic CD8+ T Cell Killing Assay
Cytotoxic CD8+ T lymphocytes (CTLs) represent a crucial component of the adaptive immune system and play a prominent role in the anti-tumor immune responses of both mice and humans.

Cytotoxic CD8+ T cells are ...
We use cookies on this site to enhance your user experience. By using our website, you are agreeing to allow the storage of cookies on your computer.